Charles River supports customers’ efforts to discover new therapies for improved human health, beginning with the earliest use of research models in discovery and continuing across the development pipeline through proof of concept. From our commitment to ensuring continuous global availability... Read More
DPT Laboratories Ltd is a leading contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid pharmaceutical dosage forms. Our capabilities span pre-formulation to clinical trial supplies, with a particular focus on semi-solids and liquids such as aerosols,... Read More
Pharmaceutical, biopharmaceutical and medical device companies rely on West for standard-setting systems and device components for parenterally administered medicines. West’s proprietary materials science, formulation research, and manufacturing innovation advance the quality, therapeutic... Read More
Helping to overcome technical challenges, including process and formulation development, technology transfer, and analytical methods development, BioPharma Solutions’ scientific teams are skilled in the development of solutions, suspensions, and freeze-dried dosage forms to help optimize product... Read more »
A broad portfolio to meet sterile needs. As a parenterals specialist, BioPharma Solutions offers unique delivery systems and a variety of manufacturing solutions to meet complex and traditional sterile manufacturing challenges. Parenteral Delivery Systems Frozen Premix System Liquid Premix... Read more »
New clinical guidelines call for increased safety and simplicity in medication delivery. Market data demonstrates that delivery which provides convenience can build clinician preference. BioPharma Solutions provides delivery systems designed to improve compliance with safety guidelines and to... Read more »
By Baxter BioPharma Solutions
Baxter BioPharma Solutions approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails enables the development scientist to design a formulation and process with meaningful ranges supported by data. This...
Read More
By Baxter BioPharma Solutions
Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical. Outsourcing of drug product manufacturing to a contract manufacturing organization with experience in handling different products in...
Read More
By Baxter BioPharma Solutions
Formulation and process development for injectable products are typically conducted at laboratory-scale. There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation is intended for lyophilization. The...
Read More